A detailed history of Wbi Investments, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wbi Investments, Inc. holds 19,415 shares of GILD stock, worth $1.77 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
19,415
Previous 9,744 99.25%
Holding current value
$1.77 Million
Previous $668,000 143.56%
% of portfolio
0.4%
Previous 0.17%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$66.59 - $83.99 $643,991 - $812,267
9,671 Added 99.25%
19,415 $1.63 Million
Q2 2024

Jul 30, 2024

BUY
$63.15 - $72.88 $615,333 - $710,142
9,744 New
9,744 $668,000
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $4.65 Million - $5.3 Million
60,198 Added 314.84%
79,318 $6.58 Million
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $35,522 - $50,997
570 Added 3.07%
19,120 $1.64 Million
Q3 2022

Oct 26, 2022

SELL
$59.54 - $68.01 $2.27 Million - $2.59 Million
-38,054 Reduced 67.23%
18,550 $1.14 Million
Q2 2022

Jul 25, 2022

BUY
$57.72 - $65.01 $945,626 - $1.07 Million
16,383 Added 40.73%
56,604 $3.5 Million
Q1 2022

May 02, 2022

SELL
$57.92 - $72.58 $359,161 - $450,068
-6,201 Reduced 13.36%
40,221 $2.39 Million
Q4 2021

Jan 28, 2022

BUY
$64.88 - $73.64 $283,590 - $321,880
4,371 Added 10.39%
46,422 $3.25 Million
Q3 2021

Nov 09, 2021

SELL
$67.69 - $73.03 $5.1 Million - $5.51 Million
-75,395 Reduced 64.2%
42,051 $2.94 Million
Q2 2021

Aug 13, 2021

BUY
$63.47 - $69.35 $7.44 Million - $8.12 Million
117,157 Added 40538.75%
117,446 $8.09 Million
Q2 2021

Aug 09, 2021

SELL
$63.47 - $69.35 $4.71 Million - $5.14 Million
-74,161 Reduced 99.61%
289 $8.09 Million
Q1 2021

May 12, 2021

BUY
$60.0 - $68.46 $4.47 Million - $5.1 Million
74,450 New
74,450 $4.81 Million
Q3 2019

Oct 29, 2019

SELL
$62.51 - $69.0 $11.8 Million - $13 Million
-188,955 Closed
0 $0
Q2 2019

Jul 23, 2019

BUY
$61.87 - $69.38 $11.7 Million - $13.1 Million
188,955 New
188,955 $12.8 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wbi Investments, Inc. Portfolio

Follow Wbi Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wbi Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Wbi Investments, Inc. with notifications on news.